$5.55
0.203.74%
Last update: Oct 22, 9:43 AM
$5.35
N/A
CytoSorbents Corp
CTSONASDAQ
CytoSorbents (CTSO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
CytoSorbents (CTSO) last issued guidance on January 12, 2026 for Q4 2025. The company guided revenue in the range of $9.2M - $9.2M for the period.
Compared to prior guidance, CytoSorbents lowered its revenue forecast from a prior range of $37M - $37M.
CytoSorbents has issued 4 guidance updates between January 31, 2023 and January 12, 2026. During this period, the company raised its outlook 2 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.80 | $-1.00 | $-1.00 | $-1.00 |
| Actual | $-1.40 | $-1.00 | $-1.40 | $-0.80 |
| Surprise | -75.0% | 0.00% | -40.0% | +20.0% |
| Revenue | ||||
| Estimate | $9.3M | $9.4M | $9.2M | $9.9M |
| Actual | $9.6M | $8.9M | $9.2M | $9.5M |
| Surprise | +3.04% | -5.35% | +0.27% | -4.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.90 | $-0.70 | $0.01 | $0.01 |
| Revenue | ||||
| Consensus | $9.9M | $10.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.40 | $-0.80 | -75.0 % |
| Q1 | May 13, 2026 | $-1.00 | $-1.00 | 0.00 % |
| Q4 | Mar 25, 2026 | $-1.40 | $-1.00 | -40.0 % |
| Q3 | Nov 13, 2025 | $-0.80 | $-1.00 | 20.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $9.63M | $9.35M | 3.04 % |
| Q1 | May 13, 2026 | $8.86M | $9.36M | -5.35 % |
| Q4 | Mar 25, 2026 | $9.23M | $9.21M | 0.27 % |
| Q3 | Nov 13, 2025 | $9.49M | $9.94M | -4.61 % |
